Earnings call transcript: Phreesia posts mixed Q2 2026 results as shares fall after hours
Phreesia released its Q2 2026 earnings report, revealing a revenue of $129.5 million, representing a 10% increase year-over-year, but falling short of analyst expectations. Adjusted earnings per share (EPS) came in at $0.03, significantly below the forecasted $0.09. The stock experienced a sharp decline of 7.59% in after-hours trading, reflecting investor concerns over the earnings miss and the company's cautious outlook.
Despite the disappointing earnings, Phreesia's adjusted EBITDA soared to $32.9 million, with a 25% margin, and the company generated positive operating and free cash flow for the ninth consecutive quarter. Revenue growth was driven by an expansion in healthcare services clients, reaching 4,744, a 36% increase year-over-year and 277% from the first quarter.
Total revenue per client stood at $27,289, a 4% year-over-year increase. Phreesia expects revenue to range between $510 million and $520 million and adjusted EBITDA between $125 million and $135 million for fiscal 2027, maintaining its focus on diverse product offerings, including the recently acquired AccessOne patient financing business.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
